Neil F. Mcfarlane - Net Worth and Insider Trading

Neil F. Mcfarlane Net Worth

The estimated net worth of Neil F. Mcfarlane is at least $504,676 dollars as of 2024-11-29. Neil F. Mcfarlane is the COO of Travere Therapeutics Inc and owns about 26,988 shares of Travere Therapeutics Inc (TVTX) stock worth over $504,676. Details can be seen in Neil F. Mcfarlane's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Neil F. Mcfarlane has not made any transactions after 2019-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Neil F. Mcfarlane

To

Neil F. Mcfarlane Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Neil F. Mcfarlane owns 4 companies in total, including Adamas Pharmaceuticals Inc (ADMS) , Travere Therapeutics Inc (TVTX) , and Collegium Pharmaceutical Inc (COLL) among others .

Click here to see the complete history of Neil F. Mcfarlane’s form 4 insider trades.

Insider Ownership Summary of Neil F. Mcfarlane

Ticker Comapny Transaction Date Type of Owner
ADMS Adamas Pharmaceuticals Inc 2020-03-18 Chief Executive Officer
TVTX Travere Therapeutics Inc 2019-05-16 Chief Operating Officer
COLL Collegium Pharmaceutical Inc 2022-04-06 director
LIMIT LIMIT 2023-10-10 director & President and CEO

Neil F. Mcfarlane Latest Holdings Summary

Neil F. Mcfarlane currently owns a total of 1 stock. Neil F. Mcfarlane owns 26,988 shares of Travere Therapeutics Inc (TVTX) as of May 16, 2019, with a value of $504,676.

Latest Holdings of Neil F. Mcfarlane

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TVTX Travere Therapeutics Inc 2019-05-16 26,988 18.70 504,676

Holding Weightings of Neil F. Mcfarlane


Neil F. Mcfarlane Form 4 Trading Tracker

According to the SEC Form 4 filings, Neil F. Mcfarlane has made a total of 0 transactions in Travere Therapeutics Inc (TVTX) over the past 5 years. The most-recent trade in Travere Therapeutics Inc is the sale of 1,968 shares on May 16, 2019, which brought Neil F. Mcfarlane around $35,916.

Insider Trading History of Neil F. Mcfarlane

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Neil F. Mcfarlane Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Neil F. Mcfarlane Ownership Network

Ownership Network List of Neil F. Mcfarlane

No Data

Ownership Network Relation of Neil F. Mcfarlane

Insider Network Chart

Neil F. Mcfarlane Owned Company Details

What does Adamas Pharmaceuticals Inc do?

Who are the key executives at Adamas Pharmaceuticals Inc?

Neil F. Mcfarlane is the Chief Executive Officer of Adamas Pharmaceuticals Inc. Other key executives at Adamas Pharmaceuticals Inc include Chief Commercial Officer Vijay Shreedhar , Chief Financial Officer Christopher B Prentiss , and director & 10 percent owner William W. Ericson .

Adamas Pharmaceuticals Inc (ADMS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Adamas Pharmaceuticals Inc (ADMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adamas Pharmaceuticals Inc (ADMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adamas Pharmaceuticals Inc (ADMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adamas Pharmaceuticals Inc Insider Transactions

No Available Data

Neil F. Mcfarlane Mailing Address

Above is the net worth, insider trading, and ownership report for Neil F. Mcfarlane. You might contact Neil F. Mcfarlane via mailing address: C/o Retrophin, Inc., 12255 El Camino Real, Suite 250, San Diego Ca 92130.

Discussions on Neil F. Mcfarlane

No discussions yet.